Please join Trevi Therapeutics for its Investor and Analyst Day in Midtown, New York. During the program, Trevi’s leadership team will outline its clinical development plans, commercial learnings, and discuss the IP strategy. The event will also feature presentations from distinguished key opinion leaders (KOLs) in chronic cough in idiopathic pulmonary fibrosis and non-IPF interstitial lung disease, as well as refractory chronic cough.

Following the conclusion of the formal program and Q&A session, attendees are welcome to stay for an optional lunch and open discussion with management and the KOLs from 12:00 pm – 1:00 pm.